The initial drug of choice is an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) to treat hypertension by targeting the underlying pathogenesis in the activation of the renin-angiotensin-aldosterone system [13]. Here, ACE is linked to hypertensive disorder.